Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Nov. 01, 2014	Nov. 02, 2013
Cash flows from operating activities:
Net loss	$ (13,849)	$ (4,639)
Adjustments to reconcile net loss to net cash used for operating activities:
Amortization of deferred gain on sale leaseback	(1,099)	(1,099)
Depreciation and amortization	17,169	13,550
Deferred taxes, net of valuation allowance	65	(3,133)
Stock compensation expense	2,203	1,492
Issuance of common stock to Board of Directors	159	227
Changes in operating assets and liabilities :
Accounts receivable	833	(2,953)
Inventories	(20,847)	(15,339)
Prepaid expenses and other current assets	(1,529)	(226)
Other assets	(321)	(742)
Accounts payable	(4,400)	5,504
Deferred rent and lease incentives	5,589	5,891
Accrued expenses and other liabilities	651	(4,031)
Net cash used for operating activities	(15,376)	(5,498)
Cash flows from investing activities:
Additions to property and equipment, net	(30,835)	(38,179)
Net cash used for investing activities	(30,835)	(38,179)
Cash flows from financing activities:
Proceeds from the exercise of stock options	123	355
Proceeds from the issuance of long-term debt	23,923	13,878
Principal payments on long-term debt	(4,640)	(33)
Costs associated with amendment to credit facility and long-term debt issuances	(598)	(454)
Net borrowings under credit facility	28,925	27,001
Net cash provided by financing activities	47,733	40,747
Net increase (decrease) in cash and cash equivalents	1,522	(2,930)
Cash and cash equivalents:
Beginning of period	4,544	8,162
End of period	$ 6,066	$ 5,232